...
首页> 外文期刊>Breast cancer research and treatment. >Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society
【24h】

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

机译:淋巴结阳性乳腺癌小肿瘤的乳腺癌特异性死亡率:韩国乳腺癌学会的一项全国性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor size and number of lymph node (LN) metastases are well known as the most important prognostic factors of breast cancer. We hypothesized that very small breast cancers with LN metastasis represent a progressive biologic behavior and evaluated tumor size stratified by LN metastasis. Data between 1990 and 2010 were obtained retrospectively from the Korean Breast Cancer Society Registry with inclusion criteria of female, non-metastatic, unilateral, and T1/2 breast cancer. We collected the following variables: age at surgery, tumor size, number of LN metastases, nuclear grade (NG), lymphovascular invasion (LVI), estrogen receptor status, progesterone receptor status, and epidermal growth factor receptor-2 status. Patient characteristics were compared by means of independent t-tests for continuous variables and the Chi-square or Fisher's exact test for categorical variables. Kaplan-Meier curves, with corresponding results of log-rank tests, were constructed for breast cancer-specific survival (BCSS). Five- and eight-year breast cancer-specific mortality (BCSM) was obtained in groups of 300 patients, followed by smoothing according to the confidence interval using the lowess method. We identified 39,826 breast cancer patients who met the inclusion criteria. Among them, 1433 (3.6 %) patients died due to breast cancer. The median follow-up duration was 63.4 (3-255) months. In the multivariate analysis, age at surgery, NG, LVI, subtype, and tumor size-nodal interactions were independently associated with BCSM. The N1 group had lower BCSS for T1a than T1b. The N2+ group also had lower BCSS for T1b than T1c or T2. In the N1 group of tumors smaller than 10 mm, 5- and 8-year BCSM decreased with larger tumor size. Patients with very small tumors with LN metastasis have decreased BCSM according to increase tumor size. Small tumors with LN metastasis could have aggressive biological behavior.
机译:众所周知,肿瘤的大小和淋巴结转移的数量是乳腺癌最重要的预后因素。我们假设具有LN转移的非常小的乳腺癌代表了渐进的生物学行为,并评估了因LN转移分层的肿瘤大小。 1990年至2010年之间的数据回顾性地从韩国乳腺癌协会登记处获得,纳入标准包括女性,非转移性,单侧和T1 / 2乳腺癌。我们收集了以下变量:手术年龄,肿瘤大小,LN转移数目,核分级(NG),淋巴管浸润(LVI),雌激素受体状态,孕激素受体状态和表皮生长因子受体2状态。通过独立t检验对连续变量进行比较,对患者特征进行了比较,对分类变量采用卡方检验或Fisher精确检验进行了比较。绘制Kaplan-Meier曲线以及相应的对数秩检验结果,以用于乳腺癌特异性存活率(BCSS)。在300名患者的小组中,分别获得了5年和8年的乳腺癌特异性死亡率(BCSM),然后使用lowess方法根据置信区间进行平滑处理。我们确定了39826名符合纳入标准的乳腺癌患者。其中,有1433名(3.6%)患者死于乳腺癌。中位随访时间为63.4(3-255)个月。在多变量分析中,手术年龄,NG,LVI,亚型和肿瘤大小淋巴结相互作用与BCSM独立相关。 N1组的T1a的BCSS低于T1b。 N2 +组的T1b BCSS也低于T1c或T2。在N1组小于10 mm的肿瘤中,随着肿瘤尺寸的增大,5年和8年BCSM下降。 LN转移非常小肿瘤的患者,随着肿瘤大小的增加,其BCSM降低。具有LN转移的小肿瘤可能具有侵袭性的生物学行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号